Analysts’ Weekly Ratings Changes for UiPath (PATH)

Several analysts have recently updated their ratings and price targets for UiPath (NYSE: PATH):

• 9/8/2026 – UiPath is now covered by Citigroup Inc.. They set a “buy” rating and a $23.00 price target on the stock.
• 9/4/2026 – UiPath had its price target raised by Royal Bank Of Canada from $15.00 to $17.00. They now have a “sector perform” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by Barclays PLC from $14.00 to $17.00. They now have an “equal weight” rating on the stock.
• 9/4/2026 – UiPath had its “buy” rating reaffirmed by HC Wainwright.
• 9/4/2026 – UiPath had its “market perform” rating reaffirmed by Oppenheimer Holdings, Inc..
• 9/4/2026 – UiPath was given a new $16.00 price target by UBS Group AG.
• 9/4/2026 – UiPath had its price target raised by TD Cowen from $13.00 to $16.00. They now have a “hold” rating on the stock.
• 9/4/2026 – UiPath had its “hold” rating reaffirmed by Canaccord Genuity Group Inc.. They now have a $17.00 price target on the stock, up from $15.00.
• 9/4/2026 – UiPath had its price target raised by Truist Financial Corporation from $12.00 to $17.00. They now have a “hold” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by Mizuho from $12.00 to $14.00. They now have a “neutral” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by Bank of America Corporation from $13.00 to $15.00. They now have an “underperform” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by Wells Fargo & Company from $13.00 to $15.00. They now have an “equal weight” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by DA Davidson from $12.00 to $16.00. They now have a “neutral” rating on the stock.
• 9/4/2026 – UiPath had its price target raised by BMO Capital Markets from $13.00 to $18.00. They now have a “market perform” rating on the stock.
• 9/3/2026 – UiPath had its price target raised by Needham & Company LLC from $15.00 to $22.00. They now have a “buy” rating on the stock.
• 8/31/2026 – UiPath had its price target raised by UBS Group AG from $12.00 to $19.00. They now have a “neutral” rating on the stock.
• 8/14/2026 – UiPath had its price target raised by Royal Bank Of Canada from $12.00 to $15.00. They now have a “sector perform” rating on the stock.

Insider Buying and Selling

In other news, CEO Daniel Dines sold 1,402,347 shares of the firm’s stock in a transaction on Wednesday, August 19th. The shares were sold at an average price of $16.07, for a total transaction of $22,535,716.29. Following the sale, the chief executive officer owned 26,491,238 shares in the company, valued at approximately $425,714,194.66. This trade represents a 5.03% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 22.44% of the stock is currently owned by corporate insiders.

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric.